EPS Diluted (Annual) Chart

View EPS Diluted (Annual) for PFE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Annual) Chart
Start Trial

Historical EPS Diluted (Annual) Data

View and export this data back to 1980. Start Trial.
Date Value
December 31, 2025 1.356
December 31, 2024 1.407
December 31, 2023 0.3738
December 31, 2022 5.471
December 31, 2021 3.880
December 31, 2020 1.626
December 31, 2019 2.868
December 31, 2018 1.866
December 31, 2017 3.517
December 31, 2016 1.17
December 31, 2015 1.113
December 31, 2014 1.414
December 31, 2013 1.689
December 31, 2012 1.304
December 31, 2011 1.106
December 31, 2010 1.02
December 31, 2009 1.23
December 31, 2008 1.189
December 31, 2007 1.183
December 31, 2006 1.52
December 31, 2005 1.02
December 31, 2004 1.49
December 31, 2003 0.22
Date Value
December 31, 2002 1.52
December 31, 2001 1.22
December 31, 2000 0.59
December 31, 1999 0.82
December 31, 1998 0.4933
December 31, 1997 0.5667
December 31, 1996 0.4983
December 31, 1995 0.4167
December 31, 1994 0.3483
December 31, 1993 0.1708
December 31, 1992 0.2708
December 31, 1991 0.1775
December 31, 1990 0.1988
December 31, 1989 0.1683
December 31, 1988 0.1958
December 31, 1987 0.17
December 31, 1986 0.00
December 31, 1985 0.00
December 31, 1984 0.00
December 31, 1983 0.00
December 31, 1982 0.00
December 31, 1981 0.00
December 31, 1980 0.00

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
Johnson & Johnson 11.03
Eli Lilly & Co. 22.95
Merck & Co., Inc. 7.281
Bristol Myers Squibb Co. 3.460
Viatris, Inc. -3.002